Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6

Current Oncology

Volumn 14, Issue 2, 2007, Pages 70-73

  Chan, Carlos H F ^a   Stanners, Clifford P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Carcinoembryonic antigen; Carcinoembryonic antigen related cell adhesion molecule 6; Colon cancer; Tumor biology

Indexed keywords

CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; GENOMIC DNA; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; COLORECTAL CANCER; GENE OVEREXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; PROGNOSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; RADIOIMMUNOTHERAPY;

EID: 41649086438     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.2007.109     Document Type: Article

References (43)

1. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-62.
2. Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP. Isolation and characterization of full-length functional CDNA clones for human carcinoembryonic antigen. Mol Cell Biol 1987;7:3221-30.
3. Hammarstrom S, Olsen A, Teglund S, Baranov V. The nature and expression of the human CEA family. In: Stanners CP, ed. Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives. Amsterdam: Harwood Academic Publishers; 1998: 1-30.
4. Zimmermann W. The nature and expression of the rodent CEA families: evolutionary considerations. In: Stanners CP, ed. Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives. Amsterdam: Harwood Academic Publishers; 1998: 31-55.
5. Zhou GQ, Zhang Y, Hammarstrom S. The carcinoembryonic antigen (CEA) gene family in non-human primates. Gene 2001; 264:105-12.
6. Paxton RJ, Mooser G, Pande H, Lee TD, Shively JE. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci U S A 1987;84:920-4.
7. Naghibalhossaini F, Yoder AD, Tobi M, Stanners CP. Evolution of a tumorigenic property conferred by glycophosphatidyl-inositol membrane anchors of CEA gene family members during the primate radiation. Mol Biol Cell 2007;[in press].
8. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-57.
9. Chu PG, Ishizawa S, Wu E, Weiss, LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and •- fetoprotein. Am J Surg Pathol 2002;26:978-88.
10. Takano T, Miyauchi A, Matsuzuka F, et al. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 1999;84:951-5.
11. Genega EM, Hutchinson B, Reuter VE, Gaudin PB. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol 2000;13:1186-91.
12. Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol 1991;7:162-6.
13. Gaglia P, Caldarola B, Bussone R, et al. Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis. Eur J Cancer Clin Oncol 1988;24:1151-5.
14. Ballesta AM, Molina R, Filella X, Jo J, Gimenez N. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol 1995;16:32-41.
15. Jantscheff P, Terracciano L, Lowy A, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 2003;21:3638-46.
16. Sakao Y, Nakazono T, Sakuragi T, Natsuaki M, Itoh T. Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung. Ann Thorac Surg 2004; 77:1157-62.
17. Eidelman FJ, Fuks A, DeMarte L, Taheri M, Stanners CP. Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J Cell Biol 1993;123:467-75.
18. Stanners CP. Contributions of the human CEA family to malignant transformation. In: Stanners CP, ed. Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives. Amsterdam: Harwood Academic Publishers; 1998: 141-54.
19. Ilantzis C, DeMarte L, Screaton RA, Stanners CP. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 2002;4:151-63.
20. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 2000;60:3419-24.
21. Soeth E, Wirth T, List HJ, et al. Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res 2001;7: 2022-30.
22. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 2004;23:465-73.
23. Jessup JM, Thomas P. CEA and metastasis: a facilitator of site-specific metastasis. In: Stanners CP, ed. Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives. Amsterdam: Harwood Academic Publishers; 1998: 195-222.
24. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004; 64:3987-93.
25. Chan CH, Cook D, Stanners CP. Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice. Carcinogenesis 2006;27:1909-16.
26. Camacho-Leal P, Zhai AB, Stanners CP. A co-clustering model involving • 5• 1 integrin for the biological effects of GPI-anchored human carcinoembryonic antigen (CEA). J Cell Physiol 2007;[in press]. [Epub February 7, 2007]
27. Duxbury MS, Ito H, Ashley SW, Whang EE. c-Src-dependent cross-talk between CEACAM6 and • v • 3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. Biochem Biophys Res Commun 2004;317: 133-41.
28. Screaton RA, DeMarte L, Draber P, Stanners CP. The specificity for the differentiation blocking activity of carcino-embryonic antigen resides in its glycophosphatidyl-inositol anchor. J Cell Biol 2000;150:613-26.
29. Nicholson TB, Stanners CP. Specific inhibition of GPI-anchored protein function by homing and self-association of specific GPI anchors. J Cell Biol 2006;175:647-59.
30. Ordonez C, Zhai AB, Camacho-Leal P, DeMarte L, Fan MM, Stanners CP. GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects though enhanced integrin • 5 • 1-fibronectin interaction. J Cell Physiol 2007; 210:757-65.
31. Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J Biol Chem 2000;275:26935-43.
32. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
33. Smith G, Carey FA, Beattie J, et al. Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A 2002;99:9433-8.
34. Takayama T, Ohi M, Hayashi T, et al. Analysis of K-ras, APC, and • -catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001;121:599-611.
35. Crawford JM. The gastrointestinal tract. In: Cotran RS, Robbins SL, Kumar V, eds. Robbins Pathologic Basis of Disease. 5th ed. Philadelphia: WB Saunders; 1994; 755-829.
36. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology 2006;49:121-31.
37. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123: 862-76.
38. Jass JR. Serrated adenoma of the colorectum and the DNA - methylator phenotype. Nat Clin Pract Oncol 2005;2:398-405.
39. Pretlow TP, Roukhadze EV, O'Riordan MA, Chan JC, Amini SB, Stellato TA. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology 1994;107:1719-25.
40. Ilantzis C, Jothy S, Alpert LC, Draber P, Stanners CP. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab Invest 1997;76:703-16.
41. Jass JR, Filipe MI, Abbas S, Falcon CA, Wilson Y, Lovell D. A morphologic and histochemical study of metaplastic polyps of the colorectum. Cancer 1984;53:510-15.
42. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 2000;156:595-605.
43. Chan CH, Stanners CP. Novel mouse model for carcino-embryonic antigen-based therapy. Mol Ther 2004;9:775-85.